 | • レポートコード：MRC2012A8885 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ソラフェニブの世界市場を広く調査・分析し、今後の市場展望をまとめております。ソラフェニブの種類別市場規模（特許医薬品、ジェネリック医薬品）、用途別市場規模（腎臓がん、肝臓がん、甲状腺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Mylan、Natco Pharma、Cipla、 ・地域別グローバル市場分析 2015年-2020年 ・ソラフェニブの北米市場（アメリカ、カナダ、メキシコ） ・ソラフェニブのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ソラフェニブのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ソラフェニブの南米市場（ブラジル、アルゼンチン） ・ソラフェニブの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：特許医薬品、ジェネリック医薬品 ・用途別分析：腎臓がん、肝臓がん、甲状腺がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Sorafenib market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sorafenib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sorafenib market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sorafenib market has been segmented into
Patented Drugs
Generic Drugs
By Application, Sorafenib has been segmented into:
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sorafenib market presented in the report. This section sheds light on the sales growth of different regional and country-level Sorafenib markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sorafenib market.
The report offers in-depth assessment of the growth and other aspects of the Sorafenib market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Sorafenib Market Share Analysis
Sorafenib competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sorafenib sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sorafenib sales, revenue and market share for each player covered in this report.
The major players covered in Sorafenib are:
Bayer
Mylan
Natco Pharma
Cipla
Among other players domestic and global, Sorafenib market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sorafenib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sorafenib, with price, sales, revenue and global market share of Sorafenib in 2018 and 2019.
Chapter 3, the Sorafenib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sorafenib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sorafenib market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sorafenib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Sorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sorafenib Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Sorafenib Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Kidney Cancer
1.3.3 Liver Cancer
1.3.4 Thyroid Cancer
1.3.5 Other
1.4 Overview of Global Sorafenib Market
1.4.1 Global Sorafenib Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Natco Pharma
2.3.1 Natco Pharma Details
2.3.2 Natco Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Natco Pharma SWOT Analysis
2.3.4 Natco Pharma Product and Services
2.3.5 Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cipla SWOT Analysis
2.4.4 Cipla Product and Services
2.4.5 Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sorafenib Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sorafenib Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sorafenib Manufacturer Market Share in 2019
3.3.2 Top 6 Sorafenib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sorafenib Sales, Revenue and Market Share by Regions
4.1.1 Global Sorafenib Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sorafenib Revenue and Market Share by Regions (2015-2020)
4.2 North America Sorafenib Sales and Growth Rate (2015-2020)
4.3 Europe Sorafenib Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sorafenib Sales and Growth Rate (2015-2020)
4.5 South America Sorafenib Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sorafenib Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sorafenib Sales, Revenue and Market Share by Country
5.1.1 North America Sorafenib Sales and Market Share by Country (2015-2020)
5.1.2 North America Sorafenib Revenue and Market Share by Country (2015-2020)
5.2 United States Sorafenib Sales and Growth Rate (2015-2020)
5.3 Canada Sorafenib Sales and Growth Rate (2015-2020)
5.4 Mexico Sorafenib Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sorafenib Sales, Revenue and Market Share by Country
6.1.1 Europe Sorafenib Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sorafenib Revenue and Market Share by Country (2015-2020)
6.2 Germany Sorafenib Sales and Growth Rate (2015-2020)
6.3 UK Sorafenib Sales and Growth Rate (2015-2020)
6.4 France Sorafenib Sales and Growth Rate (2015-2020)
6.5 Russia Sorafenib Sales and Growth Rate (2015-2020)
6.6 Italy Sorafenib Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sorafenib Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sorafenib Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sorafenib Revenue and Market Share by Regions (2015-2020)
7.2 China Sorafenib Sales and Growth Rate (2015-2020)
7.3 Japan Sorafenib Sales and Growth Rate (2015-2020)
7.4 Korea Sorafenib Sales and Growth Rate (2015-2020)
7.5 India Sorafenib Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sorafenib Sales and Growth Rate (2015-2020)
7.7 Australia Sorafenib Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sorafenib Sales, Revenue and Market Share by Country
8.1.1 South America Sorafenib Sales and Market Share by Country (2015-2020)
8.1.2 South America Sorafenib Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sorafenib Sales and Growth Rate (2015-2020)
8.3 Argentina Sorafenib Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sorafenib Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sorafenib Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sorafenib Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sorafenib Sales and Growth Rate (2015-2020)
9.3 Turkey Sorafenib Sales and Growth Rate (2015-2020)
9.4 Egypt Sorafenib Sales and Growth Rate (2015-2020)
9.5 South Africa Sorafenib Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sorafenib Sales and Market Share by Type (2015-2020)
10.2 Global Sorafenib Revenue and Market Share by Type (2015-2020)
10.3 Global Sorafenib Price by Type (2015-2020)
11 Global Sorafenib Market Segment by Application
11.1 Global Sorafenib Sales Market Share by Application (2015-2020)
11.2 Global Sorafenib Revenue Market Share by Application (2015-2020)
11.3 Global Sorafenib Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sorafenib Sales, Revenue and Growth Rate (2021-2025)
12.2 Sorafenib Market Forecast by Regions (2021-2025)
12.2.1 North America Sorafenib Market Forecast (2021-2025)
12.2.2 Europe Sorafenib Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sorafenib Market Forecast (2021-2025)
12.2.4 South America Sorafenib Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sorafenib Market Forecast (2021-2025)
12.3 Sorafenib Market Forecast by Type (2021-2025)
12.3.1 Global Sorafenib Sales Forecast by Type (2021-2025)
12.3.2 Global Sorafenib Market Share Forecast by Type (2021-2025)
12.4 Sorafenib Market Forecast by Application (2021-2025)
12.4.1 Global Sorafenib Sales Forecast by Application (2021-2025)
12.4.2 Global Sorafenib Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Sorafenib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sorafenib by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sorafenib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Sorafenib Major Business
Table 9. Bayer Sorafenib Total Revenue (USD Million) (2017-2018)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Sorafenib Product and Services
Table 12. Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Sorafenib Major Business
Table 15. Mylan Sorafenib Total Revenue (USD Million) (2017-2018)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Sorafenib Product and Services
Table 18. Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Natco Pharma Sorafenib Major Business
Table 21. Natco Pharma Sorafenib Total Revenue (USD Million) (2017-2018)
Table 22. Natco Pharma SWOT Analysis
Table 23. Natco Pharma Sorafenib Product and Services
Table 24. Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Cipla Basic Information, Manufacturing Base and Competitors
Table 26. Cipla Sorafenib Major Business
Table 27. Cipla Sorafenib Total Revenue (USD Million) (2017-2018)
Table 28. Cipla SWOT Analysis
Table 29. Cipla Sorafenib Product and Services
Table 30. Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Sorafenib Sales by Manufacturer (2018-2019) (K Units)
Table 32. Global Sorafenib Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Sorafenib Sales by Regions (2015-2020) (K Units)
Table 34. Global Sorafenib Sales Market Share by Regions (2015-2020)
Table 35. Global Sorafenib Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Sorafenib Sales by Countries (2015-2020) (K Units)
Table 37. North America Sorafenib Sales Market Share by Countries (2015-2020)
Table 38. North America Sorafenib Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Sorafenib Revenue Market Share by Countries (2015-2020)
Table 40. Europe Sorafenib Sales by Countries (2015-2020) (K Units)
Table 41. Europe Sorafenib Sales Market Share by Countries (2015-2020)
Table 42. Europe Sorafenib Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Sorafenib Sales by Regions (2015-2020) (K Units)
Table 44. Asia-Pacific Sorafenib Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Sorafenib Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Sorafenib Sales by Countries (2015-2020) (K Units)
Table 47. South America Sorafenib Sales Market Share by Countries (2015-2020)
Table 48. South America Sorafenib Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Sorafenib Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Sorafenib Sales by Countries (2015-2020) (K Units)
Table 51. Middle East & Africa Sorafenib Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Sorafenib Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Sorafenib Revenue Market Share by Countries (2015-2020)
Table 54. Global Sorafenib Sales by Type (2015-2020) (K Units)
Table 55. Global Sorafenib Sales Share by Type (2015-2020)
Table 56. Global Sorafenib Revenue by Type (2015-2020) (USD Million)
Table 57. Global Sorafenib Revenue Share by Type (2015-2020)
Table 58. Global Sorafenib Sales by Application (2015-2020) (K Units)
Table 59. Global Sorafenib Sales Share by Application (2015-2020)
Table 60. Global Sorafenib Sales Forecast by Regions (2021-2025) (K Units)
Table 61. Global Sorafenib Market Share Forecast by Regions (2021-2025)
Table 62. Global Sorafenib Sales Forecast by Type (2021-2025) (K Units)
Table 63. Global Sorafenib Market Share Forecast by Type (2021-2025)
Table 64. Global Sorafenib Sales Forecast by Application (2021-2025)
Table 65. Global Sorafenib Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sorafenib Picture
Figure 2. Global Sales Market Share of Sorafenib by Type in 2019
Figure 3. Patented Drugs Picture
Figure 4. Generic Drugs Picture
Figure 5. Sorafenib Sales Market Share by Application in 2018
Figure 6. Kidney Cancer Picture
Figure 7. Liver Cancer Picture
Figure 8. Thyroid Cancer Picture
Figure 9. Other Picture
Figure 10. Global Sorafenib Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Sorafenib Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Sorafenib Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Sorafenib Sales Market Share by Manufacturer in 2019
Figure 31. Global Sorafenib Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Sorafenib Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Sorafenib Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Sorafenib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Sorafenib Revenue Market Share by Regions (2015-2020)
Figure 38. Global Sorafenib Revenue Market Share by Regions in 2018
Figure 39. North America Sorafenib Sales and Growth Rate (2015-2020)
Figure 40. Europe Sorafenib Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sorafenib Sales and Growth Rate (2015-2020)
Figure 42. South America Sorafenib Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Sorafenib Sales and Growth Rate (2015-2020)
Figure 44. North America Sorafenib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Sorafenib Sales Market Share by Countries (2015-2020)
Figure 46. North America Sorafenib Sales Market Share by Countries in 2018
Figure 47. North America Sorafenib Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Sorafenib Revenue Market Share by Countries in 2018
Figure 49. United States Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Sorafenib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Sorafenib Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Sorafenib Revenue Market Share by Countries in 2019
Figure 55. Germany Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Sorafenib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Sorafenib Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Sorafenib Revenue Market Share by Regions 2019
Figure 63. China Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Sorafenib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Sorafenib Sales Market Share by Countries in 2019
Figure 70. South America Sorafenib Revenue Market Share by Countries in 2019
Figure 71. Brazil Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Sorafenib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Sorafenib Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Sorafenib Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Sorafenib Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Sorafenib Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Sorafenib Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Sorafenib Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Sorafenib Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Sorafenib Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Sorafenib Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Sorafenib Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Sorafenib Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…- 甲状腺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thyroid Cancer Treatment Scope and Market Size Thyroid Cancer Tre…
- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 腎臓がん治療薬の世界市場（～2026年） Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer devel…
- 腎臓がんの世界市場（～2026年） Kidney cancer is a type of cancer that starts in the cells in the kidney. The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treat…